Jane Street’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Jane Street’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-853,000	Closed	-$20.6M	–	10007
2023 Q1	$20.6M	Buy	853,000 +326,000	+62%	+$4.09M	0.01%	984
2022 Q4	$5.57M	Buy	527,000 +112,900	+27%	+$911K	﹤0.01%	2336
2022 Q3	$1.86M	Buy	414,100 +63,400	+18%	+$289K	﹤0.01%	4307
2022 Q2	$1.4M	Sell	350,700 -20,700	-6%	-$98.1K	﹤0.01%	4844
2022 Q1	$2.72M	Buy	371,400 +353,300	+1,952%	+$2.11M	﹤0.01%	4165
2021 Q4	$102K	Sell	18,100 -7,000	-28%	-$44.5K	﹤0.01%	9248
2021 Q3	$161K	Sell	25,100 -70,300	-74%	-$452K	﹤0.01%	9017
2021 Q2	$804K	Buy	+95,400	New	+$770K	﹤0.01%	6309
2020 Q4	–	Sell	-79,800	Closed	-$1.02M	–	8328
2020 Q3	$1.02M	Sell	79,800 -54,300	-40%	-$686K	﹤0.01%	4063
2020 Q2	$1.89M	Buy	+134,100	New	+$1.69M	﹤0.01%	3141

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Jane Street's PRVB Position: Q2 2023 in Review

Jane Street sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 176,649 shares — an estimated $4.26M sold.

Jane Street first reported a position in PRVB in Q1 2020 and held it in 12 quarters. The position peaked at $4.26M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Jane Street reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Jane Street sold 176,649 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $4.26M.
Jane Street first reported a position in Provention Bio, Inc. Common Stock in Q1 2020 and held it in 12 quarters.
Jane Street's Provention Bio, Inc. Common Stock position peaked at $4.26M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.